{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:39:40Z","timestamp":1789123180942,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Fakult\u00e4t Heidelberg der Universit\u00e4t Heidelberg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The blood-brain barrier (BBB) paracellular permeability must be evaluated in various contexts in vitro and in vivo, including pharmacological evaluation of drug candidates, investigations of pathological changes in disease and model development. However, most available paracellular marker substances are either radioactive, lack sensitivity and thereby require large sample volumes, or they can influence the BBB themselves via osmotic pressure. Moreover, in drug permeability studies, an adequate paracellular marker should be detectable in the same sample as the compound being tested, ideally applying the same analytical technology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We rationally designed a novel permeability marker to be highly sensitively measurable with ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS\/MS); to be not a potential substrate of solute carriers or transporters; stable against enzymatic digestion and well tolerated. We evaluated this novel permeability marker in vitro in Transwell\n                      <jats:sup>\u00ae<\/jats:sup>\n                      models with four different cell types (MDCK II, hCMEC\/D3, primary and from induced pluripotent stem cells derived brain capillary endothelial cells) and cross-validated these results with known fluorescence markers. We further analyzed its in vivo pharmacokinetics and brain-to-plasma ratio in healthy Swiss mice. Possible interactions with LAT-1 and PepT1 were evaluated with uptake and\/or inhibition assays.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Based on non-canonical and \u1d05-dipeptide structure, the developed marker \u1d05-methyl-tyrosinyl-\u1d05-ornithine (\u1d05-Tyr(Me)Orn) is hydrophilic and with low molecular weight (309 Da), it enables a low endogenous background and is readily available through peptide synthesis, also as isotopically labeled derivative. The developed UPLC-MS\/MS quantification assay allows a highly sensitive measurement in different matrices (lower limit of quantification: 0.05 ng\/mL cell medium, lysed cells, 0.1 ng\/mL mouse plasma; 3 ng\/g, mouse brain). In the well-known MDCK II Transwell\n                      <jats:sup>\u00ae<\/jats:sup>\n                      model, it revealed a suitable P\n                      <jats:sub>app<\/jats:sub>\n                      of 5.13\u2009\u00b1\u20091.08\u2009\u00d7\u200910\n                      <jats:sup>\u2212\u20097<\/jats:sup>\n                      cm\/s. Using the marker \u1d05-Tyr(Me)Orn it was further possible to compare the tightness of three brain capillary endothelial cell models. The time dependent distribution and in vivo pharmacokinetics was determined in healthy Swiss mice and revealed a constantly low brain concentration and brain-to-plasma ratio.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We developed a highly feasible new paracellular marker, easily adaptable in various experimental designs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12987-026-00806-5","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T09:27:05Z","timestamp":1775813225000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Novel paracellular marker based on \u1d05-dipeptide structure for highly sensitive quantification with UPLC-MS\/MS for in vitro and in vivo blood-brain barrier permeability analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Cindy","family":"Bay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"M\u00fchlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Carolin","family":"Stingl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gzona","family":"Bajraktari-Sylejmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Burhenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"806_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12987-019-0123-z","volume":"16","author":"C Greene","year":"2019","unstructured":"Greene C, Hanley N, Campbell M. Claudin-5: gatekeeper of neurological function. Fluids barriers CNS. 2019;16:3.","journal-title":"Fluids barriers CNS"},{"key":"806_CR2","doi-asserted-by":"publisher","first-page":"914","DOI":"10.3389\/fphys.2020.00914","volume":"11","author":"JJ Lochhead","year":"2020","unstructured":"Lochhead JJ, Yang J, Ronaldson PT, Davis TP. Structure, function, and regulation of the blood-brain barrier tight junction in central nervous system disorders. Front Physiol. 2020;11:914.","journal-title":"Front Physiol"},{"key":"806_CR3","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1084\/jem.20171406","volume":"214","author":"A Montagne","year":"2017","unstructured":"Montagne A, Zhao Z, Zlokovic BV. Alzheimer\u2019s disease: a matter of blood-brain barrier dysfunction? J Exp Med. 2017;214:3151\u201369.","journal-title":"J Exp Med"},{"key":"806_CR4","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1523\/JNEUROSCI.6409-11.2012","volume":"32","author":"J Liu","year":"2012","unstructured":"Liu J, Jin X, Liu KJ, Liu W. Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. J Neurosci. 2012;32:3044\u201357.","journal-title":"J Neurosci"},{"key":"806_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<637::AID-CNCR22>3.0.CO;2-Y","volume":"88","author":"ND Doolittle","year":"2000","unstructured":"Doolittle ND, Miner ME, Hall WA, Siegal T, Hanson EJ, Osztie E, et al. Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors. Cancer. 2000;88:637\u201347.","journal-title":"Cancer"},{"key":"806_CR6","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1158\/0008-5472.CAN-12-0128","volume":"72","author":"N McDannold","year":"2012","unstructured":"McDannold N, Arvanitis CD, Vykhodtseva N, Livingstone MS. Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques. Cancer Res. 2012;72:3652\u201363.","journal-title":"Cancer Res"},{"key":"806_CR7","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s007010050227","volume":"140","author":"S Sato","year":"1998","unstructured":"Sato S, Kawase T, Harada S, Takayama H, Suga S. Effect of hyperosmotic solutions on human brain tumour vasculature. Acta Neurochir. 1998;140:1135\u201341.","journal-title":"Acta Neurochir"},{"key":"806_CR8","doi-asserted-by":"publisher","first-page":"114314","DOI":"10.1016\/j.jconrel.2025.114314","volume":"388","author":"S Inoue","year":"2025","unstructured":"Inoue S, Shirakura K, Shirono A, Taguchi J, Ikeda Y, Tomita S, et al. Claudin 5-binding small molecule transiently opens the blood-brain barrier and safely enhances brain drug delivery. J Control Release. 2025;388:114314.","journal-title":"J Control Release"},{"key":"806_CR9","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1021\/acs.molpharmaceut.9b00042","volume":"16","author":"A Di Marco","year":"2019","unstructured":"Di Marco A, Gonzalez Paz O, Fini I, Vignone D, Cellucci A, Battista MR, et al. Application of an in vitro blood-brain barrier model in the selection of experimental drug candidates for the treatment of Huntington\u2019s Disease. Mol Pharm. 2019;16:2069\u201382.","journal-title":"Mol Pharm"},{"key":"806_CR10","unstructured":"Goldmann EE. Vitalf\u00e4rbung am Zentralnervensystem: Beitrag zur Physio-Pathologie des Plexus Chorioideus und der Hirnh\u00e4ute. Verlag der k\u00f6nigl. Akademie der Wissenschaften; 1913."},{"key":"806_CR11","unstructured":"Ehrlich P. Das Sauerstoff- Bed\u00fcrfniss des Organismus: Eine farbenanalytische Studie. Verlag von August Hirschwald, Berlin. 1885."},{"key":"806_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3389\/fnins.2015.00385","volume":"9","author":"NR Saunders","year":"2015","unstructured":"Saunders NR, Dziegielewska KM, Mollgard K, Habgood MD. Markers for blood-brain barrier integrity: how appropriate is Evans blue in the twenty-first century and what are the alternatives? Front Neurosci. 2015;9:385.","journal-title":"Front Neurosci"},{"key":"806_CR13","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s10695-021-01015-7","volume":"47","author":"J Dragojevic","year":"2021","unstructured":"Dragojevic J, Marakovic N, Popovic M, Smital T. Zebrafish (Danio rerio) Oatp2b1 as a functional ortholog of the human OATP2B1 transporter. Fish Physiol Biochem. 2021;47:1837\u201349.","journal-title":"Fish Physiol Biochem"},{"key":"806_CR14","doi-asserted-by":"crossref","unstructured":"Choi JJ, Wang S, Tung YS, Morrison B 3rd, Konofagou EE. Molecules of various pharmacologically-relevant sizes can cross the ultrasound-induced blood-brain barrier opening in vivo. Ultrasound Med Biol. 2010;36:58\u201367.","DOI":"10.1016\/j.ultrasmedbio.2009.08.006"},{"key":"806_CR15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1083\/jcb.200302070","volume":"161","author":"T Nitta","year":"2003","unstructured":"Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol. 2003;161:653\u201360.","journal-title":"J Cell Biol"},{"key":"806_CR16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.brainres.2006.08.085","volume":"1120","author":"TA Brooks","year":"2006","unstructured":"Brooks TA, Ocheltree SM, Seelbach MJ, Charles RA, Nametz N, Egleton RD, et al. Biphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory pain. Brain Res. 2006;1120:172\u201382.","journal-title":"Brain Res"},{"key":"806_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12987-020-00224-1","volume":"17","author":"B Noorani","year":"2020","unstructured":"Noorani B, Chowdhury EA, Alqahtani F, Ahn Y, Patel D, Al-Ahmad A, et al. LC-MS\/MS-based in vitro and in vivo investigation of blood-brain barrier integrity by simultaneous quantitation of mannitol and sucrose. Fluids barriers CNS. 2020;17:61.","journal-title":"Fluids barriers CNS"},{"key":"806_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0006-8993(98)01282-7","volume":"818","author":"H Franke","year":"1999","unstructured":"Franke H, Galla H-J, Beuckmann CT. An improved low-permeability in vitro-model of the blood\u2013brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol. Brain Res. 1999;818:65\u201371.","journal-title":"Brain Res"},{"key":"806_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.brainres.2013.04.006","volume":"1521","author":"A Patabendige","year":"2013","unstructured":"Patabendige A, Skinner RA, Morgan L, Abbott NJ. A detailed method for preparation of a functional and flexible blood-brain barrier model using porcine brain endothelial cells. Brain Res. 2013;1521:16\u201330.","journal-title":"Brain Res"},{"key":"806_CR20","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1039\/C6AY00061D","volume":"8","author":"H Licea-Perez","year":"2016","unstructured":"Licea-Perez H, Junnotula V, Zohrabian S, Karlinsey M. Development of a multi-sugar LC-MS\/MS assay using simple chemical derivatization with acetic anhydride. Anal Methods. 2016;8:3023\u201333.","journal-title":"Anal Methods"},{"key":"806_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jchromb.2016.02.017","volume":"1015\u20131016","author":"MK Miah","year":"2016","unstructured":"Miah MK, Bickel U, Mehvar R. Development and validation of a sensitive UPLC-MS\/MS method for the quantitation of [(13)C]sucrose in rat plasma, blood, and brain: Its application to the measurement of blood-brain barrier permeability. J Chromatogr B. 2016;1015\u20131016:105\u201310.","journal-title":"J Chromatogr B"},{"key":"806_CR22","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/pharmaceutics13071019","volume":"13","author":"T von Linde","year":"2021","unstructured":"von Linde T, Bajraktari-Sylejmani G, Haefeli WE, Burhenne J, Weiss J, Sauter M. Rapid and sensitive quantification of intracellular glycyl-sarcosine for semi-high-throughput screening for inhibitors of PEPT-1. Pharmaceutics. 2021;13:1019.","journal-title":"Pharmaceutics"},{"key":"806_CR23","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/S0196-9781(02)00192-4","volume":"23","author":"JW Crim","year":"2002","unstructured":"Crim JW, Garczynski SF, Brown MR. Approaches to radioiodination of insect neuropeptides. Peptides. 2002;23:2045\u201351.","journal-title":"Peptides"},{"key":"806_CR24","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.3390\/ijms23073637","volume":"23","author":"C Bay","year":"2022","unstructured":"Bay C, Bajraktari-Sylejmani G, Haefeli WE, Burhenne J, Weiss J, Sauter M. Functional characterization of the solute carrier LAT-1 (SLC7A5\/SLC2A3) in human brain capillary endothelial cells with rapid UPLC-MS\/MS quantification of intracellular isotopically labelled L-leucine. Int J Mol Sci. 2022;23:5029.","journal-title":"Int J Mol Sci"},{"key":"806_CR25","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. Bioanalytical method validation and sample analysis M10. 2022. https:\/\/database.ich.org\/sites\/default\/files\/M10_Guideline_Step4_2022_0524.pdf. Accessed 14 Nov 2025."},{"key":"806_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jchromb.2005.11.009","volume":"830","author":"BK Matuszewski","year":"2006","unstructured":"Matuszewski BK. Standard line slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioanalysis. J Chromatogr B. 2006;830:293\u2013300.","journal-title":"J Chromatogr B"},{"key":"806_CR27","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/S0022-3565(25)13060-7","volume":"253","author":"WM Pardridge","year":"1990","unstructured":"Pardridge WM, Triguero D, Cancilla JY. Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier. J Pharmacol Exp Ther. 1990;253:884\u201391.","journal-title":"J Pharmacol Exp Ther"},{"key":"806_CR28","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1002\/ejoc.201601638","volume":"2017","author":"L Cavina","year":"2017","unstructured":"Cavina L, van der Born D, Klaren PHM, Feiters MC, Boerman OC, Rutjes F. Design of radioiodinated pharmaceuticals: structural features affecting metabolic stability towards in vivo deiodination. Eur J Org Chem. 2017;2017:3387\u2013414.","journal-title":"Eur J Org Chem"},{"key":"806_CR29","doi-asserted-by":"publisher","first-page":"5769","DOI":"10.1038\/s41598-019-42099-9","volume":"9","author":"M Tanaka","year":"2019","unstructured":"Tanaka M, Dohgu S, Komabayashi G, Kiyohara H, Takata F, Kataoka Y, et al. Brain-transportable dipeptides across the blood-brain barrier in mice. Sci Rep. 2019;9:5769.","journal-title":"Sci Rep"},{"key":"806_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00233302","volume":"145","author":"D Meredith","year":"1995","unstructured":"Meredith D, Boyd CAR. Oligopeptide transport by epithelial cells. J Membrane Biol. 1995;145:1\u201312.","journal-title":"J Membrane Biol"},{"key":"806_CR31","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1113\/jphysiol.1982.sp014121","volume":"324","author":"CAR Boyd","year":"1982","unstructured":"Boyd CAR, Ward MR. A micro-electrode study of oligopeptide absorption by the small intestinal epithelium of necturus maculosus. J Physiol. 1982;324:411\u201328.","journal-title":"J Physiol"},{"key":"806_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1113\/jphysiol.1995.sp020656","volume":"484","author":"N Lister","year":"1995","unstructured":"Lister N, Sykes AP, Bailey PD, Boyd CAR, Bronk JR. Dipeptide transport and hydrolysis in isolated loops of rat small intestine: effects of stereospecificity. J Physiol. 1995;484:173\u201382.","journal-title":"J Physiol"},{"key":"806_CR33","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.3390\/pharmaceutics15102473","volume":"15","author":"MM Parvez","year":"2023","unstructured":"Parvez MM, Sadighi A, Ahn Y, Keller SF, Enoru JO. Uptake transporters at the blood-brain barrier and their role in brain drug disposition. Pharmaceutics. 2023;15:2473.","journal-title":"Pharmaceutics"},{"key":"806_CR34","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.mam.2012.11.003","volume":"34","author":"DE Smith","year":"2013","unstructured":"Smith DE, Clemencon B, Hediger MA. Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications. Mol Aspects Med. 2013;34:323\u201336.","journal-title":"Mol Aspects Med"},{"key":"806_CR35","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/jnc.12687","volume":"129","author":"Y Hu","year":"2014","unstructured":"Hu Y, Xie Y, Keep RF, Smith DE. Divergent developmental expression and function of the proton-coupled oligopeptide transporters PepT2 and PhT1 in regional brain slices of mouse and rat. J Neurochem. 2014;129:955\u201365.","journal-title":"J Neurochem"},{"key":"806_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1006\/bbrc.1998.8566","volume":"246","author":"Y-J Fei","year":"1998","unstructured":"Fei Y-J, Liu J-C, Fujita T, Liang R, Ganapathy V, Leibach FH. Identification of a potential substrate binding domain in the mammalian peptide transporters PEPT1 and PEPT2 using PEPT1-PEPT2 and PEPT2-PEPT1 chimeras. Biochem Biophys Res Commun. 1998;246:39\u201344.","journal-title":"Biochem Biophys Res Commun"},{"key":"806_CR37","doi-asserted-by":"publisher","first-page":"eabk3259","DOI":"10.1126\/sciadv.abk3259","volume":"7","author":"M Killer","year":"2021","unstructured":"Killer M, Jiri Wald J, Pieprzyk J, Marlovits TC, L\u00f6w C. Structural snapshots of human PepT1 and PepT2 reveal mechanistic insights into substrate and drug transport across epithelial membranes. Sci Adv. 2021;7:eabk3259.","journal-title":"Sci Adv"},{"key":"806_CR38","doi-asserted-by":"publisher","first-page":"23629","DOI":"10.1074\/jbc.273.37.23629","volume":"273","author":"Y Kanai","year":"1998","unstructured":"Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem. 1998;273:23629\u201332.","journal-title":"J Biol Chem"},{"key":"806_CR39","doi-asserted-by":"publisher","first-page":"12079","DOI":"10.1073\/pnas.96.21.12079","volume":"96","author":"RJ Boado","year":"1999","unstructured":"Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM. Selective expression of the large neutral amino acid transporter at the blood\u2013brain barrier. Proc Natl Acad Sci U S A. 1999;96:12079\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"806_CR40","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3390\/biom13030552","volume":"13","author":"VK Khavinson","year":"2023","unstructured":"Khavinson VK, Linkova NS, Rudskoy AI, Petukhov MG. Feasibility of transport of 26 biologically active ultrashort peptides via LAT and PEPT family transporters. Biomolecules. 2023;13:552.","journal-title":"Biomolecules"},{"key":"806_CR41","doi-asserted-by":"crossref","unstructured":"Weksler BB, Subileau EA, Perri\u00e8re N, Charneau P, Holloway K, Leveque M, et al. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 2005;1872\u20134.","DOI":"10.1096\/fj.04-3458fje"},{"key":"806_CR42","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1111\/jnc.16125","volume":"168","author":"V Taggi","year":"2024","unstructured":"Taggi V, Schafer AM, Dolce A, Meyer Zu Schwabedissen HE. A face-to-face comparison of the BBB cell models hCMEC\/D3 and hBMEC for their applicability to adenoviral expression of transporters. J Neurochem. 2024;168:2611\u201320.","journal-title":"J Neurochem"},{"key":"806_CR43","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1021\/mp3004308","volume":"10","author":"S Ohtsuki","year":"2013","unstructured":"Ohtsuki S, Ikeda C, Uchida Y, Sakamoto Y, Miller F, Glacial F, et al. Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC\/D3 as a human blood-brain barrier model. Mol Pharm. 2013;10:289\u201396.","journal-title":"Mol Pharm"},{"key":"806_CR44","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1083\/jcb.77.3.853","volume":"77","author":"M Cereijido","year":"1978","unstructured":"Cereijido M, Robbins ES, Dolan WJ, Rotunno CA, Sabatini DD. Polarized monolayers formed by epithelial cells on a permeable and translucent support. J Cell Biol. 1978;77:853\u201380.","journal-title":"J Cell Biol"},{"key":"806_CR45","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ejpb.2012.07.020","volume":"82","author":"E Hellinger","year":"2012","unstructured":"Hellinger E, Veszelka S, Toth AE, Walter F, Kittel A, Bakk ML, et al. Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models. Eur J Pharm Biopharm. 2012;82:340\u201351.","journal-title":"Eur J Pharm Biopharm"},{"key":"806_CR46","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/pharmaceutics13030303","volume":"13","author":"J Wen","year":"2021","unstructured":"Wen J, Gao X, Zhang Q, et al. Optimization of tilmicosin-loaded nanostructured lipid carriers using orthogonal design for overcoming oral administration obstacle. Pharmaceutics. 2021;13:303.","journal-title":"Pharmaceutics"},{"key":"806_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/2045-8118-10-33","volume":"10","author":"DE Eigenmann","year":"2013","unstructured":"Eigenmann DE, Xue G, Kim KS, Moses AV, Hamburger M, Oufir M. Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC\/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies. Fluids Barriers CNS. 2013;10:33.","journal-title":"Fluids Barriers CNS"},{"key":"806_CR48","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/nprot.2010.76","volume":"5","author":"MJ Bernas","year":"2010","unstructured":"Bernas MJ, Cardoso FL, Daley SK, Weinand ME, Campos AR, Ferreira AJ, et al. Establishment of primary cultures of human brain microvascular endothelial cells to provide an in vitro cellular model of the blood-brain barrier. Nat Protoc. 2010;5:1265\u201372.","journal-title":"Nat Protoc"},{"key":"806_CR49","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.stemcr.2019.05.008","volume":"12","author":"EH Neal","year":"2019","unstructured":"Neal EH, Marinelli NA, Shi Y, McClatchey PM, Balotin KM, Gullett DR, et al. A simplified, fully defined differentiation scheme for producing blood-brain barrier endothelial cells from human iPSCs. Stem Cell Rep. 2019;12:1380\u20138.","journal-title":"Stem Cell Rep"},{"key":"806_CR50","doi-asserted-by":"publisher","first-page":"e1701679","DOI":"10.1126\/sciadv.1701679","volume":"3","author":"T Qian","year":"2017","unstructured":"Qian T, Maguire SE, Canfield SG, Bao X, Olson WR, Shusta EV, et al. Directed differentiation of human pluripotent stem cells to blood-brain barrier endothelial cells. Sci Adv. 2017;3:e1701679.","journal-title":"Sci Adv"},{"key":"806_CR51","doi-asserted-by":"publisher","first-page":"e2016950118","DOI":"10.1073\/pnas.2016950118","volume":"118","author":"TM Lu","year":"2021","unstructured":"Lu TM, Houghton S, Magdeldin T, Duran JGB, Minotti AP, Snead A, et al. Pluripotent stem cell-derived epithelium misidentified as brain microvascular endothelium requires ETS factors to acquire vascular fate. Proc Natl Acad Sci U S A. 2021;118:e2016950118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"806_CR52","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s12035-013-8581-9","volume":"49","author":"F Mina","year":"2014","unstructured":"Mina F, Comim CM, Dominguini D, Cassol OJ Jr., Igna D, Ferreira DM. Il1-beta involvement in cognitive impairment after sepsis. Mol Neurobiol. 2014;49:1069\u201376.","journal-title":"Mol Neurobiol"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-026-00806-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00806-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00806-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:45:29Z","timestamp":1781646329000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12987-026-00806-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["806"],"URL":"https:\/\/doi.org\/10.1186\/s12987-026-00806-5","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}